Contributions of the intestinal microbiome in lung immunity

European Journal of Immunology

Volumn 48, Issue 1, 2018, Pages 39-49

  McAleer, Jeremy P ^a   Kolls, Jay K ^b  

^a MARSHALL UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Diet; Intestine; Microbiota; T cell

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PREBIOTIC AGENT; PROBIOTIC AGENT; ANTIINFECTIVE AGENT; FATTY ACID;

ASTHMA; BACTERIAL COLONIZATION; DIET; HELMINTH; HUMAN; IMMUNITY; INTESTINE FLORA; LUNG FUNCTION; LUNG INFECTION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; DYSBIOSIS; ENZYME ACTIVATION; IMMUNOLOGY; INTESTINE; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTI-BACTERIAL AGENTS; ASTHMA; DYSBIOSIS; ENZYME ACTIVATION; FATTY ACIDS; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINES; LUNG; PNEUMONIA; PROBIOTICS; RECEPTORS, G-PROTEIN-COUPLED; T-LYMPHOCYTES, REGULATORY;

EID: 85040354358     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201646721     Document Type: Review

References (131)

1. Ferreira, C. M., Vieira, A. T., Vinolo, M. A., Oliveira, F. A., Curi, R. and Martins Fdos, S., The central role of the gut microbiota in chronic inflammatory diseases. J. Immunol. Res. 2014. 2014: 689492.
2. Kraft, S. C., Earle, R. H., Roesler, M. and Esterly, J. R., Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch. Intern. Med. 1976. 136: 454–459.
3. von Wichert, P., Barth, P. and von Wichert, G., Tracheal and bronchial involvement in colitis ulcerosa - a colo-bronchitic syndrome? A case report and some additional considerations. Ger. Med. Sci. 2015. 13: Doc03.
4. Corren, J., Asthma phenotypes and endotypes: an evolving paradigm for classification. Discov. Med. 2013. 15: 243–249.
5. Sideleva, O., Black, K. and Dixon, A. E., Effects of obesity and weight loss on airway physiology and inflammation in asthma. Pulm. Pharmacol. Ther. 2013. 26: 455–458.
6. Barach, A. L. and Garthwaite, B., Physiologic and antibiotic therapy of intractable bronchial asthma. Ann. Allergy. 1947. 5: 297–316.
7. Garthwaite, B. and Barach, A. L., Penicillin aerosol therapy in bronchiectasis, lung abscess and chronic bronchitis. Am. J. Med. 1947. 3: 261–293.
8. Vutcovici, M., Brassard, P. and Bitton, A., Inflammatory bowel disease and airway diseases. World J. Gastroenterol. 2016. 22: 7735–7741.
9. Balfour Sartor, R. Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications. J. Clin. Gastroenterol. 2007. 41(Suppl 1): S37–S43.
10. Reid, G., Younes, J. A., Van der Mei, H. C., Gloor, G. B., Knight, R. and Busscher, H. J., Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat. Rev. Microbiol. 2011. 9: 27–38.
11. Stokholm, J., Thorsen, J., Chawes, B. L., Schjorring, S., Krogfelt, K. A., Bonnelykke, K. and Bisgaard, H., Cesarean section changes neonatal gut colonization. J. Allergy Clin. Immunol. 2016. 138: 881–889 e882.
12. Salminen, S., Gibson, G. R., McCartney, A. L. and Isolauri, E., Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 2004. 53: 1388–1389.
13. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y. et al., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013. 504: 446–450.
14. Ray, A., Khare, A., Krishnamoorthy, N., Qi, Z. and Ray, P., Regulatory T cells in many flavors control asthma. Mucosal Immunol. 2010. 3: 216–229.
15. Ray, A., Raundhal, M., Oriss, T. B., Ray, P. and Wenzel, S. E., Current concepts of severe asthma. J. Clin. Invest. 2016. 126: 2394–2403.
16. Verhulst, S. L., Vael, C., Beunckens, C., Nelen, V., Goossens, H. and Desager, K., A longitudinal analysis on the association between antibiotic use, intestinal microflora, and wheezing during the first year of life. J. Asthma 2008. 45: 828–832.
17. Orivuori, L., Mustonen, K., de Goffau, M. C., Hakala, S., Paasela, M., Roduit, C., Dalphin, J. C. et al., High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6. Clin. Exp. Allergy 2015. 45: 928–939.
18. van Nimwegen, F. A., Penders, J., Stobberingh, E. E., Postma, D. S., Koppelman, G. H., Kerkhof, M., Reijmerink, N. E. et al., Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J. Allergy Clin. Immunol. 2011. 128: 948–955 e941–943.
19. Frank, D. N., St Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N. and Pace, N. R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U S A 2007. 104: 13780–13785.
20. Treem, W. R., Ahsan, N., Shoup, M. and Hyams, J. S., Fecal short-chain fatty acids in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 1994. 18: 159–164.
21. Harig, J. M., Soergel, K. H., Komorowski, R. A. and Wood, C. M., Treatment of diversion colitis with short-chain-fatty acid irrigation. N. Engl. J. Med. 1989. 320: 23–28.
22. Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C. et al., Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009. 461: 1282–1286.
23. Hirasawa, A., Hara, T., Katsuma, S., Adachi, T., Tsujimoto, G., Free fatty acid receptors and drug discovery. Biol. Pharm. Bull. 2008. 31: 1847–1851.
24. Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C. et al., Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 2014. 20: 159–166.
25. Thorburn, A. N., McKenzie, C. I., Shen, S., Stanley, D., Macia, L., Mason, L. J., Roberts, L. K. et al., Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat. Commun. 2015. 6: 7320. https://doi.org/10.1038/ncomms8320.
26. Belkaid, Y. and Naik, S., Compartmentalized and systemic control of tissue immunity by commensals. Nat. Immunol. 2013. 14: 646–653.
27. Jarchum, I. and Pamer, E. G., Regulation of innate and adaptive immunity by the commensal microbiota. Curr. Opin. Immunol. 2011. 23: 353–360.
28. Kamada, N., Chen, G. Y., Inohara, N. and Nunez, G., Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 2013. 14: 685–690.
29. den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D. J. and Bakker, B. M., The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 2013. 54: 2325–2340.
30. Everard, A. and Cani, P. D., Gut microbiota and GLP-1. Rev. Endocr. Metab. Disord. 2014. 15: 189–196.
31. Elson, C. O., Cong, Y., McCracken, V. J., Dimmitt, R. A., Lorenz, R. G. and Weaver, C. T., Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol. Rev. 2005. 206: 260–276.
32. Wells, J. M., Brummer, R. J., Derrien, M., MacDonald, T. T., Troost, F., Cani, P. D., Theodorou, V. et al., Homeostasis of the gut barrier and potential biomarkers. Am. J. Physiol. Gastrointest. Liver Physiol. 2017. 312: G171–G193.
33. Vaishnava, S., Yamamoto, M., Severson, K. M., Ruhn, K. A., Yu, X., Koren, O., Ley, R. et al., The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 2011. 334: 255–258.
34. Walsh, D., McCarthy, J., O'Driscoll, C. and Melgar, S., Pattern recognition receptors–molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine Growth Factor Rev. 2013. 24: 91–104.
35. Al Nabhani, Z., Dietrich, G., Hugot, J. P. and Barreau, F., Nod2: The intestinal gate keeper. PLoS Pathog. 2017. 13: e1006177.
36. Pugliese, D., Felice, C., Papa, A., Gasbarrini, A., Rapaccini, G. L., Guidi, L. and Armuzzi, A., Anti TNF-alpha therapy for ulcerative colitis: current status and prospects for the future. Expert Rev. Clin. Immunol. 2017. 13: 223–233.
37. Uhlig, H. H., McKenzie, B. S., Hue, S., Thompson, C., Joyce-Shaikh, B., Stepankova, R., Robinson, N. et al., Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006. 25: 309–318.
38. Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Forster, I. and Akira, S., Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999. 10: 39–49.
39. Eun, C. S., Mishima, Y., Wohlgemuth, S., Liu, B., Bower, M., Carroll, I. M. and Sartor, R. B., Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10-/- mice. Infect. Immun. 2014. 82: 2239–2246.
40. Rakoff-Nahoum, S., Hao, L. and Medzhitov, R., Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 2006. 25: 319–329.
41. Sartor, R. B., Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006. 3: 390–407.
42. Duchmann, R., Kaiser, I., Hermann, E., Mayet, W., Ewe, K. and Meyer zum Buschenfelde, K. H., Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 1995. 102: 448–455.
43. Iijima, H., Takahashi, I., Kishi, D., Kim, J. K., Kawano, S., Hori, M. and Kiyono, H., Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice. J. Exp. Med. 1999. 190: 607–615.
44. Josefowicz, S. Z., Niec, R. E., Kim, H. Y., Treuting, P., Chinen, T., Zheng, Y., Umetsu, D. T. et al., Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 2012. 482: 395–399.
45. Powrie, F., Leach, M. W., Mauze, S., Menon, S., Caddle, L. B. and Coffman, R. L., Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1994. 1: 553–562.
46. Zhang, Z., Zheng, M., Bindas, J., Schwarzenberger, P. and Kolls, J. K., Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel Dis. 2006. 12: 382–388.
47. Suri-Payer, E. and Cantor, H., Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J. Autoimmun. 2001. 16: 115–123.
48. Hand, T. W., Dos Santos, L. M., Bouladoux, N., Molloy, M. J., Pagan, A. J., Pepper, M., Maynard, C. L. et al., Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science 2012. 337: 1553–1556.
49. Kumar, P., Monin, L., Castillo, P., Elsegeiny, W., Horne, W., Eddens, T., Vikram, A. et al., Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation. Immunity 2016. 44: 659–671.
50. Lindemans, C. A., Calafiore, M., Mertelsmann, A. M., O'Connor, M. H., Dudakov, J. A., Jeng, R. R., Velardi, E. et al., Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 2015. 528: 560–564.
51. Atarashi, K., Tanoue, T., Ando, M., Kamada, N., Nagano, Y., Narushima, S., Suda, W. et al., Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 2015. 163: 367–380.
52. Tan, T. G., Sefik, E., Geva-Zatorsky, N., Kua, L., Naskar, D., Teng, F., Pasman, L. et al., Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc. Natl. Acad. Sci. U S A 2016. 113: E8141–E8150.
53. Tanabe, S. The effect of probiotics and gut microbiota on Th17 cells. Int. Rev. Immunol. 2013. 32: 511–525.
54. Fantini, M. C., Rizzo, A., Fina, D., Caruso, R., Becker, C., Neurath, M. F., Macdonald, T. T. et al., IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. Eur. J. Immunol. 2007. 37: 3155–3163.
55. Abt, M. C., Osborne, L. C., Monticelli, L. A., Doering, T. A., Alenghat, T., Sonnenberg, G. F., Paley, M. A. et al., Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012. 37: 158–170.
56. Fagundes, C. T., Amaral, F. A., Vieira, A. T., Soares, A. C., Pinho, V., Nicoli, J. R., Vieira, L. Q. et al., Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice. J. Immunol. 2012. 188: 1411–1420.
57. Arts, R. J., Joosten, L. A. and Netea, M. G., Immunometabolic circuits in trained immunity. Semin. Immunol. 2016. 28: 425–430.
58. McAleer, J. P., Nguyen, N. L., Chen, K., Kumar, P., Ricks, D. M., Binnie, M., Armentrout, R. A. et al., Pulmonary Th17 Antifungal Immunity Is Regulated by the Gut Microbiome. J. Immunol. 2016. 197: 97–107.
59. Gauguet, S., D'Ortona, S., Ahnger-Pier, K., Duan, B., Surana, N. K., Lu, R., Cywes-Bentley, C. et al., Intestinal microbiota of mice influences resistance to staphylococcus aureus pneumonia. Infect. Immun. 2015. 83: 4003–4014.
60. Schuijt, T. J., Lankelma, J. M., Scicluna, B. P., de Sousa e Melo, F., Roelofs, J. J., de Boer, J. D., Hoogendijk, A. J. et al., The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 2016. 65: 575–583.
61. Kim, H. Y., Lee, H. J., Chang, Y. J., Pichavant, M., Shore, S. A., Fitzgerald, K. A., Iwakura, Y. et al., Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat. Med. 2014. 20: 54–61.
62. Bonnegarde-Bernard, A., Jee, J., Fial, M. J., Aeffner, F., Cormet-Boyaka, E., Davis, I. C., Lin, M. et al., IKKbeta in intestinal epithelial cells regulates allergen-specific IgA and allergic inflammation at distant mucosal sites. Mucosal Immunol. 2014. 7: 257–267.
63. Zhang, Z., Shi, L., Pang, W., Liu, W., Li, J., Wang, H. and Shi, G., Dietary fiber intake regulates intestinal microflora and inhibits ovalbumin-induced allergic airway inflammation in a mouse model. PLoS One 2016. 11: e0147778.
64. Hougee, S., Vriesema, A. J., Wijering, S. C., Knippels, L. M., Folkerts, G., Nijkamp, F. P., Knol, J. et al., Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study. Int. Arch. Allergy Immunol. 2010. 151: 107–117.
65. Sagar, S., Vos, A. P., Morgan, M. E., Garssen, J., Georgiou, N. A., Boon, L., Kraneveld, A. D. et al., The combination of Bifidobacterium breve with non-digestible oligosaccharides suppresses airway inflammation in a murine model for chronic asthma. Biochim. Biophys. Acta 2014. 1842: 573–583.
66. Johnson, J. L., Jones, M. B. and Cobb, B. A., Bacterial capsular polysaccharide prevents the onset of asthma through T-cell activation. Glycobiology 2015. 25: 368–375.
67. Kepert, I., Fonseca, J., Muller, C., Milger, K., Hochwind, K., Kostic, M., Fedoseeva, M. et al., D-tryptophan from probiotic bacteria influences the gut microbiome and allergic airway disease. J. Allergy Clin. Immunol. 2016. 139: 1525–1535.
68. Lee, M. Y., Ahn, K. S., Kwon, O. K., Kim, M. J., Kim, M. K., Lee, I. Y., Oh, S. R. et al., Anti-inflammatory and anti-allergic effects of kefir in a mouse asthma model. Immunobiology 2007. 212: 647–654.
69. Russell, S. L., Gold, M. J., Hartmann, M., Willing, B. P., Thorson, L., Wlodarska, M., Gill, N. et al., Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012. 13: 440–447.
70. Kim, Y. G., Udayanga, K. G., Totsuka, N., Weinberg, J. B., Nunez, G. and Shibuya, A., Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE(2). Cell Host Microbe. 2014. 15: 95–102.
71. Noverr, M. C., Noggle, R. M., Toews, G. B. and Huffnagle, G. B., Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 2004. 72: 4996–5003.
72. Olszak, T., An, D., Zeissig, S., Vera, M. P., Richter, J., Franke, A., Glickman, J. N. et al., Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012. 336: 489–493.
73. Huang, F., Qiao, H. M., Yin, J. N., Gao, Y., Ju, Y. H. and Li, Y. N., Early-life exposure to clostridium leptum causes pulmonary immunosuppression. PLoS One 2015. 10: e0141717.
74. Li, Y. N., Huang, F., Liu, L., Qiao, H. M., Li, Y. and Cheng, H. J., Effect of oral feeding with Clostridium leptum on regulatory T-cell responses and allergic airway inflammation in mice. Ann. Allergy Asthma Immunol. 2012. 109: 201–207.
75. MacSharry, J., O'Mahony, C., Shalaby, K. H., Sheil, B., Karmouty-Quintana, H., Shanahan, F. and Martin, J. G., Immunomodulatory effects of feeding with Bifidobacterium longum on allergen-induced lung inflammation in the mouse. Pulm. Pharmacol. Ther. 2012. 25: 325–334.
76. Arnold, I. C., Dehzad, N., Reuter, S., Martin, H., Becher, B., Taube, C. and Muller, A., Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J. Clin. Invest. 2011. 121: 3088–3093.
77. Engler, D. B., Reuter, S., van Wijck, Y., Urban, S., Kyburz, A., Maxeiner, J., Martin, H. et al., Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10. Proc. Natl. Acad. Sci. U S A 2014. 111: 11810–11815.
78. Khare, A., Krishnamoorthy, N., Oriss, T. B., Fei, M., Ray, P. and Ray, A., Cutting edge: inhaled antigen upregulates retinaldehyde dehydrogenase in lung CD103+ but not plasmacytoid dendritic cells to induce Foxp3 de novo in CD4+ T cells and promote airway tolerance. J. Immunol. 2013. 191: 25–29.
79. Reibman, J., Marmor, M., Filner, J., Fernandez-Beros, M. E., Rogers, L., Perez-Perez, G. I. and Blaser, M. J., Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One 2008. 3: e4060.
80. Hussain, K., Letley, D. P., Greenaway, A. B., Kenefeck, R., Winter, J. A., Tomlinson, W., Rhead, J. et al., Helicobacter pylori-mediated protection from allergy is associated with IL-10-secreting peripheral blood regulatory T cells. Front. Immunol. 2016. 7: 71. https://doi.org/10.3389/fimmu.2016.00071.
81. Codolo, G., Mazzi, P., Amedei, A., Del Prete, G., Berton, G., D'Elios, M. M. and de Bernard, M., The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma. Cell Microbiol. 2008. 10: 2355–2363.
82. Chen, Y. and Blaser, M. J., Inverse associations of Helicobacter pylori with asthma and allergy. Arch. Intern. Med. 2007. 167: 821–827.
83. Lapin, B., Piorkowski, J., Ownby, D., Freels, S., Chavez, N., Hernandez, E., Wagner-Cassanova, C. et al., Relationship between prenatal antibiotic use and asthma in at-risk children. Ann. Allergy Asthma Immunol. 2015. 114: 203–207.
84. Metsala, J., Lundqvist, A., Virta, L. J., Kaila, M., Gissler, M. and Virtanen, S. M., Prenatal and post-natal exposure to antibiotics and risk of asthma in childhood. Clin. Exp. Allergy 2015. 45: 137–145.
85. Mulder, B., Pouwels, K. B., Schuiling-Veninga, C. C., Bos, H. J., de Vries, T. W., Jick, S. S. and Hak, E., Antibiotic use during pregnancy and asthma in preschool children: the influence of confounding. Clin. Exp. Allergy 2016. 46: 1214–1226.
86. Korpela, K., Salonen, A., Virta, L. J., Kekkonen, R. A., Forslund, K., Bork, P. and de Vos, W. M., Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat. Commun. 2016. 7: 10410.
87. Abrahamsson, T. R., Jakobsson, H. E., Andersson, A. F., Bjorksten, B., Engstrand, L. and Jenmalm, M. C., Low gut microbiota diversity in early infancy precedes asthma at school age. Clin. Exp. Allergy 2014. 44: 842–850.
88. Nermes, M., Niinivirta, K., Nyland, L., Laitinen, K., Matomaki, J., Salminen, S. and Isolauri, E., Perinatal pet exposure, faecal microbiota, and wheezy bronchitis: is there a connection? ISRN Allergy 2013. 2013: 827934.
89. Arrieta, M. C., Stiemsma, L. T., Dimitriu, P. A., Thorson, L., Russell, S., Yurist-Doutsch, S., Kuzeljevic et al., Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med. 2015. 7: 307ra152.
90. Fujimura, K. E., Sitarik, A. R., Havstad, S., Lin, D. L., Levan, S., Fadrosh, D., Panzer, A. R. et al., Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat. Med. 2016. 22: 1187–1191.
91. Arrieta, M. C., Sadarangani, M., Brown, E. M., Russell, S. L., Nimmo, M., Dean, J., Turvey, S. E. et al., A humanized microbiota mouse model of ovalbumin-induced lung inflammation. Gut Microbes 2016. 7: 342–352.
92. Hevia, A., Milani, C., Lopez, P., Donado, C. D., Cuervo, A., Gonzalez, S., Suarez, A. et al., Allergic Patients with Long-Term Asthma Display Low Levels of Bifidobacterium adolescentis. PLoS One 2016. 11: e0147809.
93. Birzele, L. T., Depner, M., Ege, M. J., Engel, M., Kublik, S., Bernau, C., Loss, G. J. et al., Environmental and mucosal microbiota and their role in childhood asthma. Allergy 2017. 72: 109–119.
94. Ciaccio, C. E., Barnes, C., Kennedy, K., Chan, M., Portnoy, J. and Rosenwasser, L., Home dust microbiota is disordered in homes of low-income asthmatic children. J. Asthma 2015. 52: 873–880.
95. Laursen, M. F., Zachariassen, G., Bahl, M. I., Bergstrom, A., Host, A., Michaelsen, K. F. and Licht, T. R., Having older siblings is associated with gut microbiota development during early childhood. BMC Microbiol. 2015. 15: 154. https://doi.org/10.1186/s12866-015-0477-6.
96. Wu, P., Feldman, A. S., Rosas-Salazar, C., James, K., Escobar, G., Gebretsadik, T., Li, S. X. et al., Relative Importance and Additive Effects of Maternal and Infant Risk Factors on Childhood Asthma. PLoS One 2016. 11: e0151705.
97. Vael, C., Vanheirstraeten, L., Desager, K. N. and Goossens, H., Denaturing gradient gel electrophoresis of neonatal intestinal microbiota in relation to the development of asthma. BMC Microbiol. 2011. 11: 68. https://doi.org/10.1186/1471-2180-11-68.
98. Dzidic, M., Abrahamsson, T. R., Artacho, A., Bjorksten, B., Collado, M. C., Mira, A. and Jenmalm, M. C., Aberrant IgA responses to the gut microbiota during infancy precede asthma and allergy development. J. Allergy Clin. Immunol. 2017. 139: 1017–1025 e1014.
99. Fiocchi, A., Burks, W., Bahna, S. L., Bielory, L., Boyle, R. J., Cocco, R., Dreborg, S. et al., Clinical use of probiotics in pediatric allergy (CUPPA): a world allergy organization position paper. World Allergy Organ. J. 2012. 5: 148–167.
100. Collins, S. and Reid, G., Distant site effects of ingested prebiotics. Nutrients 2016. 8: 523. https://doi.org/10.3390/nu8090523.
101. Schouten, B., Van Esch, B. C., Kormelink, T. G., Moro, G. E., Arslanoglu, S., Boehm, G., Knippels, L. M. et al., Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy. Pediatr. Allergy Immunol. 2011. 22: 537–542.
102. Williams, N. C., Johnson, M. A., Shaw, D. E., Spendlove, I., Vulevic, J., Sharpe, G. R. and Hunter, K. A., A prebiotic galactooligosaccharide mixture reduces severity of hyperpnoea-induced bronchoconstriction and markers of airway inflammation. Br. J. Nutr. 2016. 116: 798–804.
103. Halnes, I., Baines, K. J., Berthon, B. S., MacDonald-Wicks, L. K., Gibson, P. G. and Wood, L. G., soluble fibre meal challenge reduces airway inflammation and expression of GPR43 and GPR41 in asthma. Nutrients 2017. 9: 57. https://doi.org/10.3390/nu9010057.
104. Verheijden, K. A., Willemsen, L. E., Braber, S., Leusink-Muis, T., Delsing, D. J., Garssen, J., Kraneveld, A. D. et al., Dietary galacto-oligosaccharides prevent airway eosinophilia and hyperresponsiveness in a murine house dust mite-induced asthma model. Respir. Res. 2015. 16: 17. https://doi.org/10.1186/s12931-015-0171-0.
105. Verheijden, K. A., Willemsen, L. E., Braber, S., Leusink-Muis, T., Jeurink, P. V., Garssen, J., Kraneveld, A. D. et al., The development of allergic inflammation in a murine house dust mite asthma model is suppressed by synbiotic mixtures of non-digestible oligosaccharides and Bifidobacterium breve M-16V. Eur. J. Nutr. 2016. 55: 1141–1151.
106. Vos, A. P., van Esch, B. C., Stahl, B., M'Rabet, L., Folkerts, G., Nijkamp, F. P. and Garssen, J., Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice. Int. Immunopharmacol. 2007. 7: 1582–1587.
107. Konieczna, P., Groeger, D., Ziegler, M., Frei, R., Ferstl, R., Shanahan, F., Quigley, E. M. et al., Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 2012. 61: 354–366.
108. Miraglia Del Giudice, M., Maiello, N., Decimo, F., Fusco, N., D' Agostino, B., Sullo, N., Capasso, M. et al., Airways allergic inflammation and L. reuterii treatment in asthmatic children. J. Biol. Regul. Homeost. Agents 2012. 26: S35–S40.
109. Blumer, N., Sel, S., Virna, S., Patrascan, C. C., Zimmermann, S., Herz, U., Renz, H. et al., Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring. Clin. Exp. Allergy 2007. 37: 348–357.
110. Feleszko, W., Jaworska, J., Rha, R. D., Steinhausen, S., Avagyan, A., Jaudszus, A., Ahrens, B. et al., Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin. Exp. Allergy 2007. 37: 498–505.
111. Fonseca, V. M., Milani, T. M. S., Prado, R., Bonato, V., Ramos, S. G., Martins, F. S., Vianna, E. O. et al., Oral administration of Saccharomyces cerevisiae UFMG A-905 prevents allergic asthma in mice. Respirology 2017. 22: 905–912.
112. Forsythe, P., Inman, M. D. and Bienenstock, J., Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am. J. Respir. Crit. Care Med. 2007. 175: 561–569.
113. Hong, H. J., Kim, E., Cho, D. and Kim, T. S., Differential suppression of heat-killed lactobacilli isolated from kimchi, a Korean traditional food, on airway hyper-responsiveness in mice. J. Clin. Immunol. 2010. 30: 449–458.
114. Juan, Z., Zhao-Ling, S., Ming-Hua, Z., Chun, W., Hai-Xia, W., Meng-Yun, L., Jian-Qiong, H. et al., Oral administration of Clostridium butyricum CGMCC0313-1 reduces ovalbumin-induced allergic airway inflammation in mice. Respirology 2017. 22: 898–904.
115. Jensen, M. P., Meldrum, S., Taylor, A. L., Dunstan, J. A. and Prescott, S. L., Early probiotic supplementation for allergy prevention: long-term outcomes. J. Allergy Clin. Immunol. 2012. 130: 1209–1211 e1205.
116. Rose, M. A., Stieglitz, F., Koksal, A., Schubert, R., Schulze, J. and Zielen, S., Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk. Clin. Exp. Allergy 2010. 40: 1398–1405.
117. Lee, S. C., Yang, Y. H., Chuang, S. Y., Huang, S. Y. and Pan, W. H., Reduced medication use and improved pulmonary function with supplements containing vegetable and fruit concentrate, fish oil and probiotics in asthmatic school children: a randomised controlled trial. Br. J. Nutr. 2013. 110: 145–155.
118. van der Aa, L. B., van Aalderen, W. M., Heymans, H. S., Henk Sillevis Smitt, J., Nauta, A. J., Knippels, L. M., Ben Amor, K. et al., Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis. Allergy 2011. 66: 170–177.
119. Abrahamsson, T. R., Jakobsson, T., Bottcher, M. F., Fredrikson, M., Jenmalm, M. C., Bjorksten, B. and Oldaeus, G., Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2007. 119: 1174–1180.
120. Abrahamsson, T. R., Jakobsson, T., Bjorksten, B., Oldaeus, G. and Jenmalm, M. C., No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. Pediatr. Allergy Immunol. 2013. 24: 556–561.
121. Kukkonen, A. K., Kuitunen, M., Savilahti, E., Pelkonen, A., Malmberg, P. and Makela, M., Airway inflammation in probiotic-treated children at 5 years. Pediatr. Allergy Immunol. 2011. 22: 249–251.
122. Simpson, M. R., Dotterud, C. K., Storro, O., Johnsen, R. and Oien, T., Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial. BMC Dermatol. 2015. 15: 13. https://doi.org/10.1186/s12895-015-0030-1.
123. van de Pol, M. A., Lutter, R., Smids, B. S., Weersink, E. J. and van der Zee, J. S., Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. Allergy 2011. 66: 39–47.
124. Liao, H. Y., Tao, L., Zhao, J., Qin, J., Zeng, G. C., Cai, S. W., Li, Y. et al., Clostridium butyricum in combination with specific immunotherapy converts antigen-specific B cells to regulatory B cells in asthmatic patients. Sci. Rep. 2016. 6: 20481.
125. Jerzynska, J., Stelmach, W., Balcerak, J., Woicka-Kolejwa, K., Rychlik, B., Blauz, A., Wachulec, M. et al., Effect of Lactobacillus rhamnosus GG and vitamin D supplementation on the immunologic effectiveness of grass-specific sublingual immunotherapy in children with allergy. Allergy Asthma Proc. 2016. 37: 324–334.
126. Helmby, H., Human helminth therapy to treat inflammatory disorders - where do we stand? BMC Immunol. 2015. 16: 12. https://doi.org/10.1186/s12865-015-0074-3.
127. de Almeida, T. V., Fernandes, J. S., Lopes, D. M., Andrade, L. S., Oliveira, S. C., Carvalho, E. M., Araujo, M. I. et al., Schistosoma mansoni antigens alter activation markers and cytokine profile in lymphocytes of patients with asthma. Acta Trop. 2017. 166: 268–279.
128. Jabbari Azad, F., Kiaee, F., Rezaei, A., Farid Hosseini, R., Soleimani, N. and Borji, H., Downregulation of immune responses in asthmatic humans by ES products of Marshallagia marshalli. Clin. Respir. J. 2017. 11: 83–89.
129. Zaiss, M. M., Rapin, A., Lebon, L., Dubey, L. K., Mosconi, I., Sarter, K., Piersigilli, A. et al., The intestinal microbiota contributes to the ability of helminths to modulate allergic inflammation. Immunity 2015. 43: 998–1010.
130. Quinton, L. J., Blahna, M. T., Jones, M. R., Allen, E., Ferrari, J. D., Hilliard, K. L., Zhang, X. et al., Hepatocyte-specific mutation of both NF-kappaB RelA and STAT3 abrogates the acute phase response in mice. J. Clin. Invest. 2012. 122: 1758–1763.
131. Hilliard, K. L., Allen, E., Traber, K. E., Yamamoto, K., Stauffer, N. M., Wasserman, G. A., Jones, M. R. et al., The lung-liver axis: a requirement for maximal innate immunity and hepatoprotection during pneumonia. Am. J. Respir. Cell Mol. Biol. 2015. 53: 378–390.